Starpharma Holdings Limited
SPHRY · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -29.4% | 90.9% | -15.9% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -63.7% | 92.4% | 28.1% | 36.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -166.2% | -116.2% | -392.4% | -306% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -170.8% | -98.5% | -360.1% | -312.9% |
| EPS Diluted | -0.24 | -0.2 | -0.38 | -0.4 |
| % Growth | -20% | 47.4% | 5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |